Candel Therapeutics, Inc. Common Stock CADL
$13.13
+6.32%
at last close
Analyst Consensus
- Consensus Rating
- Buy (7 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $19.86
- Implied Upside
- +51.2%
- Price Target Range
- $12.00 – $26.00
- Analysts (12 mo)
- 8
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-14 | B of A SecuritiesAlec Stranahan |
Maintains | Neutral | $9 → $12 |
| 2026-08-13 | HC Wainwright & Co.Andres Y. Maldonado |
Reiterates | Buy | $23 |
| 2026-07-13 | StifelStephen Willey |
Initiates coverage on | Buy | $22 |
| 2026-04-20 | Cantor Fitzgerald |
Initiates coverage on | Overweight | — |
| 2026-03-18 | CitigroupYigal Nochomovitz |
Maintains | Buy | $22 → $26 |
| 2026-03-13 | CitigroupYigal Nochomovitz |
Maintains | Buy | $24 → $22 |
| 2026-03-13 | Canaccord GenuityJohn Newman |
Maintains | Buy | $25 |
| 2025-12-08 | Stephens & Co.Sudan Loganathan |
Reiterates | Overweight | $15 |
| 2025-11-14 | CitigroupYigal Nochomovitz |
Maintains | Buy | $25 → $24 |
| 2025-10-28 | Stephens & Co.Sudan Loganathan |
Initiates coverage on | Overweight | $15 |
| 2025-10-21 | LifeSci Capital |
Initiates coverage on | Outperform | $16 |
| 2025-09-29 | HC Wainwright & Co.Andres Y. Maldonado |
Reiterates | Buy | $23 |
| 2025-09-03 | B of A SecuritiesAlec Stranahan |
Downgrades | Buy → Neutral | $13 → $7 |
| 2025-06-30 | HC Wainwright & Co.Andrew Fein |
Assumes | Buy | $23 |
| 2025-04-11 | HC Wainwright & Co.Vernon Bernardino |
Reiterates | Buy | $19 |
| 2025-03-14 | HC Wainwright & Co.Vernon Bernardino |
Reiterates | Buy | $19 |
| 2025-02-26 | Canaccord GenuityJohn Newman |
Maintains | Buy | $20 → $25 |
| 2025-02-26 | HC Wainwright & Co.Vernon Bernardino |
Reiterates | Buy | $19 |
| 2025-02-20 | CitigroupYigal Nochomovitz |
Initiates coverage on | Buy | $25 |
| 2025-02-19 | Canaccord GenuityJohn Newman |
Initiates coverage on | Buy | $20 |
| 2025-02-07 | B of A SecuritiesAlec Stranahan |
Initiates coverage on | Buy | $15 |
| 2024-12-18 | HC Wainwright & Co.Vernon Bernardino |
Reiterates | Buy | $11 → $19 |
| 2024-11-18 | HC Wainwright & Co.Vernon Bernardino |
Reiterates | Buy | $11 |
| 2023-11-13 | HC Wainwright & Co.Vernon Bernardino |
Reiterates | Buy | $11 |
| 2023-05-22 | HC Wainwright & Co.Vernon Bernardino |
Reiterates | Buy | $11 |
| 2023-05-15 | BMO CapitalEvan David Seigerman |
Maintains | Outperform | $9 → $3 |
| 2023-03-31 | Credit SuisseJudah Frommer |
Maintains | Outperform | $8 → $7 |
| 2022-12-07 | Credit SuisseJudah Frommer |
Maintains | Outperform | $10 → $8 |
| 2022-12-02 | HC Wainwright & Co.Vernon Bernardino |
Initiates coverage on | Buy | $11 |
| 2022-03-31 | BMO CapitalEvan Seigerman |
Maintains | Outperform | $18 → $12 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $13.13
- Market Cap
- $1.00 billion
- 52-Week Range
- $4.35 – $13.82
- Average Volume
- 1.30 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.